198 related articles for article (PubMed ID: 17911600)
1. Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells.
Silver PB; Agarwal RK; Su SB; Suffia I; Grajewski RS; Luger D; Chan CC; Mahdi RM; Nickerson JM; Caspi RR
J Immunol; 2007 Oct; 179(8):5146-58. PubMed ID: 17911600
[TBL] [Abstract][Full Text] [Related]
2. Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity.
Grajewski RS; Silver PB; Agarwal RK; Su SB; Chan CC; Liou GI; Caspi RR
J Exp Med; 2006 Apr; 203(4):851-6. PubMed ID: 16585264
[TBL] [Abstract][Full Text] [Related]
3. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis.
Xu H; Wawrousek EF; Redmond TM; Nickerson JM; Wiggert B; Chan CC; Caspi RR
Eur J Immunol; 2000 Jan; 30(1):272-8. PubMed ID: 10602050
[TBL] [Abstract][Full Text] [Related]
5. Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells.
Cui Y; Shao H; Lan C; Nian H; O'Brien RL; Born WK; Kaplan HJ; Sun D
J Immunol; 2009 Jul; 183(1):560-7. PubMed ID: 19542467
[TBL] [Abstract][Full Text] [Related]
6. Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis.
Silver PB; Horai R; Chen J; Jittayasothorn Y; Chan CC; Villasmil R; Kesen MR; Caspi RR
J Immunol; 2015 Apr; 194(7):3011-9. PubMed ID: 25716996
[TBL] [Abstract][Full Text] [Related]
7. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.
Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J
EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776
[TBL] [Abstract][Full Text] [Related]
8. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis.
Keino H; Takeuchi M; Usui Y; Hattori T; Yamakawa N; Kezuka T; Sakai JI; Usui M
Br J Ophthalmol; 2007 Jan; 91(1):105-10. PubMed ID: 16943228
[TBL] [Abstract][Full Text] [Related]
9. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis.
Hara Y; Caspi RR; Wiggert B; Chan CC; Streilein JW
Curr Eye Res; 1992; 11 Suppl():97-100. PubMed ID: 1424755
[TBL] [Abstract][Full Text] [Related]
10. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
[TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein.
Hara Y; Caspi RR; Wiggert B; Chan CC; Wilbanks GA; Streilein JW
J Immunol; 1992 Mar; 148(6):1685-92. PubMed ID: 1531843
[TBL] [Abstract][Full Text] [Related]
12. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
13. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV
Front Immunol; 2020; 11():2071. PubMed ID: 33013877
[TBL] [Abstract][Full Text] [Related]
14. Interphotoreceptor retinoid-binding protein (IRBP)-deficient C57BL/6 mice have enhanced immunological and immunopathogenic responses to IRBP and an altered recognition of IRBP epitopes.
Avichezer D; Liou GI; Chan CC; Lewis GM; Wiggert B; Donoso LA; Nickerson JM; Crawford MA; Caspi RR
J Autoimmun; 2003 Nov; 21(3):185-94. PubMed ID: 14599843
[TBL] [Abstract][Full Text] [Related]
15. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827
[TBL] [Abstract][Full Text] [Related]
16. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
17. Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen.
Horai R; Silver PB; Chen J; Agarwal RK; Chong WP; Jittayasothorn Y; Mattapallil MJ; Nguyen S; Natarajan K; Villasmil R; Wang P; Karabekian Z; Lytton SD; Chan CC; Caspi RR
J Autoimmun; 2013 Aug; 44():21-33. PubMed ID: 23810578
[TBL] [Abstract][Full Text] [Related]
18. Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.
Hsu SM; Mathew R; Taylor AW; Stein-Streilein J
Clin Exp Immunol; 2014 Apr; 176(1):37-48. PubMed ID: 24266626
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of experimental autoimmune uveitis by retinal photoreceptor antigens coupled to spleen cells.
Dua HS; Gregerson DS; Donoso LA
Cell Immunol; 1992 Feb; 139(2):292-305. PubMed ID: 1733504
[TBL] [Abstract][Full Text] [Related]
20. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
